Boundless Bio, Inc.

BOLD Healthcare Biotechnology

In the quarter to June 2026, EPS fell 51.4%, free cash flow fell 76.9% and total debt fell 6.85%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

2.34 0.01 −0.43%
Market cap
$53.5M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22
Total current assets
109.61 154.39 124.20 68.04
Total non-current assets
47.45 52.02 5.69 8.79
Total Assets
157.06 206.41 129.89 76.83
Total current liabilities
12.54 8.14 9.36 7.73
Total non-current liabilities
45.87 47.63 — 2.85
Total liabilities
58.41 55.77 9.36 10.58
Common Equity (Total)
98.65 150.64 (127.08) (81.70)
Shareholders Equity (Total)
98.65 150.64 120.54 66.25
Total Debt
45.87 47.63 — 2.85

Show all line items

In millions of $ except per-share values · columns are period end dates